Dr. Lachant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# Box
Rochester, NY 14642Phone+1 585-275-2874Fax+1 585-756-5111
Education & Training
- University of RochesterResidency, Pulmonary Disease and Critical Care Medicine, 2017
- University of RochesterResidency, Internal Medicine, 2011 - 2014
- Philadelphia College of Osteopathic MedicineClass of 2011
Certifications & Licensure
- NY State License 2012 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Home Rehabilitation After Acute Pulmonary Embolism Start of enrollment: 2022 Dec 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 10 citationsHeart rate monitoring improves clinical assessment during 6-min walk.Daniel J. Lachant, Allison Light, Melissa Offen, Jamie L Adams, R. James White
Pulmonary Circulation. 2020-12-09 - 11 citationsLow dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized ratsDaniel J. Lachant, David F. Meoli, Deborah Haight, Jason A. Lyons, Robert F. Swarthout
Experimental Lung Research. 2018-01-30 - 6 citationsClinical and imaging outcomes after intermediate- or high-risk pulmonary embolus.Daniel J. Lachant, Christina Bach, Bennett L. Wilson, Vaseem U. Chengazi, Bruce I. Goldman
Pulmonary Circulation. 2020-09-21
Press Mentions
- United Therapeutics to Feature Clinical Data Across Its Commercial and Development Portfolio at the 2022 American Thoracic Society International ConferenceApril 29th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: